Teachers Retirement System of The State of Kentucky Has $4.54 Million Holdings in Encompass Health Co. (NYSE:EHC)

Teachers Retirement System of The State of Kentucky reduced its position in Encompass Health Co. (NYSE:EHC - Free Report) by 22.2% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 47,006 shares of the company's stock after selling 13,450 shares during the period. Teachers Retirement System of The State of Kentucky's holdings in Encompass Health were worth $4,543,000 as of its most recent SEC filing.

A number of other institutional investors have also modified their holdings of EHC. CIBC Asset Management Inc grew its stake in Encompass Health by 3.5% during the third quarter. CIBC Asset Management Inc now owns 2,957 shares of the company's stock worth $286,000 after buying an additional 100 shares during the period. Commonwealth Equity Services LLC raised its position in Encompass Health by 1.3% in the second quarter. Commonwealth Equity Services LLC now owns 9,845 shares of the company's stock valued at $845,000 after purchasing an additional 123 shares during the period. V Square Quantitative Management LLC lifted its stake in shares of Encompass Health by 53.0% during the third quarter. V Square Quantitative Management LLC now owns 404 shares of the company's stock worth $39,000 after purchasing an additional 140 shares in the last quarter. Verdence Capital Advisors LLC boosted its position in shares of Encompass Health by 4.6% in the third quarter. Verdence Capital Advisors LLC now owns 3,670 shares of the company's stock worth $355,000 after buying an additional 160 shares during the period. Finally, Mount Yale Investment Advisors LLC raised its holdings in shares of Encompass Health by 6.6% during the 2nd quarter. Mount Yale Investment Advisors LLC now owns 2,749 shares of the company's stock valued at $236,000 after buying an additional 170 shares during the period. Hedge funds and other institutional investors own 97.25% of the company's stock.

Analyst Upgrades and Downgrades

EHC has been the subject of several recent research reports. Barclays increased their price objective on shares of Encompass Health from $109.00 to $116.00 and gave the company an "overweight" rating in a research report on Tuesday, October 29th. Royal Bank of Canada boosted their price objective on shares of Encompass Health from $105.00 to $110.00 and gave the stock an "outperform" rating in a report on Wednesday, October 30th. KeyCorp raised their target price on Encompass Health from $115.00 to $117.00 and gave the company an "overweight" rating in a research note on Tuesday, October 29th. UBS Group boosted their price target on Encompass Health from $100.00 to $110.00 and gave the stock a "buy" rating in a research note on Wednesday, September 25th. Finally, Truist Financial restated a "buy" rating and set a $116.00 price objective (up from $108.00) on shares of Encompass Health in a report on Wednesday, October 30th. Nine equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Buy" and an average price target of $107.11.

Encompass Health Price Performance

EHC traded down $0.47 on Friday, reaching $98.19. The company had a trading volume of 523,446 shares, compared to its average volume of 638,715. The company has a market capitalization of $9.89 billion, a P/E ratio of 23.72, a PEG ratio of 1.34 and a beta of 0.86. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.88. The company has a fifty day moving average of $99.35 and a 200-day moving average of $92.49. Encompass Health Co. has a one year low of $65.33 and a one year high of $104.55.

Encompass Health (NYSE:EHC - Get Free Report) last posted its quarterly earnings data on Monday, October 28th. The company reported $1.03 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.94 by $0.09. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. The business had revenue of $1.35 billion during the quarter, compared to analysts' expectations of $1.33 billion. During the same period last year, the firm posted $0.86 earnings per share. The business's revenue was up 11.9% on a year-over-year basis. As a group, equities research analysts anticipate that Encompass Health Co. will post 4.29 earnings per share for the current year.

Encompass Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Investors of record on Thursday, January 2nd will be issued a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 0.69%. The ex-dividend date is Thursday, January 2nd. Encompass Health's payout ratio is 16.43%.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.